WHO Almost Set to Begin Clinical Trials of Coronavirus Vaccines in Nigeria

Browse By

220 new cases of COVID-19 recorded in Nigeria

220 new cases of COVID19 were recorded in Nigeria on Saturday, May 2nd.

According to the NCDC, out of the 220 new cases, 62 were recorded in Lagos, 52 in FCT, 31 in Kaduna, 13 in Sokoto, 10 in Kebbi, 9 in Yobe, 6 in Borno, 5 in Edo, 5 in Bauchi, 4 in Gombe, 4 in Enugu, 4 in Oyo, 3 in Zamfara, 2 in Nasarawa, 2 in Osun, 2 in Ebonyi, 2 in Kwara, 2 in Kano and 2 in Plateau state.

NCDC

@NCDCgov

220 new cases of ;

62-Lagos
52-FCT
31-Kaduna
13-Sokoto
10-Kebbi
9-Yobe
6-Borno
5-Edo
5-Bauchi
4-Gombe
4-Enugu
4-Oyo
3-Zamfara
2-Nasarawa
2-Osun
2-Ebonyi
2-Kwara
2-Kano
2-Plateau

2388 confirmed cases of in Nigeria
Discharged: 385
Deaths: 85

View image on Twitter

 

WHO is getting ready to begin clinical trials of coronavirus vaccines in Nigeria

The World Health Organisation (WHO) has revealed that Nigeria has expressed interest to be part of the global solidarity drug trial to combat COVID-19. The WHO launched solidarity drug trials for these specific drugs hydroxychloroquine, chloroquine phosphate, and remdesivir in April, Daily Trust reports.

Speaking at the joint national briefing of the presidential task force (PTF) on COVID-19, Fiona Braka, the officer in charge, WHO Nigeria, said efforts are underway to start the process in the country. She said more than 100 countries have joined the solidarity clinical trial, which was launched by WHO and some partners, to help find an effective treatment for COVID-19.

She said over 1,200 patients have been randomized from the first five countries to evaluate the “safety and efficacy of drug combinations”. Braka also said a total of 89 vaccines are being developed globally, including seven in clinical evaluation and several therapeutics in clinical trials.

See also  Investing In Nigeria And Nigerian Startups